Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCTs031250403) titled 'Rapid Peripheral Blood Stem Cell Collection with Plerixafor Single Agent' on Oct. 1.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, other
Primary Sponsor: Maekawa Takaaki
Condition:
Healthy subjects
Intervention:
After obtaining written consent from the research subjects at an outpatient clinic of the National Defense Medical College Hospital two to eight weeks prior to the date of peripheral blood stem cell collection, a medical interview, medical examination, blood test, urinalysis, chest X-ray, and electrocardiogram will be ...